Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

Published on January 11, 2024

We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well!

Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisi
More information on the CARE and JUSTICE studies: https://kidneycareandjustice.com/

Continue reading on website
Other news

New Era Act Introduced in Congress

December 22, 2023
We are thrilled to share that the New Era of Preventing End-Stage Kidney Disease Act (“New Era Act”), which ISGD has been advocating for in partnership with NephCure, has been officially introduced in this session of Congress. This legislation, introduced by Representatives Gus Bilirakis (R-FL) and Terri Sewell (D-AL), holds the potential for significant improvements in rare kidney disease (RKD) r

Episode 4: NephMadness Special! Anna Burgner on Preeclampsia

March 1, 2024
It's March, and that means it's time for NephMadness! Every year, our friends at AJKDBlog pit 16 unique regions of nephrology against each other in a basketball-style tournament. Prepare for the Preeclampsia region by listening to this special episode, where Anna Burgner from Vanderbilt University joins Kenar and Koyal to discuss recent discoveries in preeclampsia (the world's most common glomerul